Log In
Print this Print this

Lodonal (IRT-103 LDN)

  Manage Alerts
Collapse Summary General Information
Company Immune Therapeutics Inc.
DescriptionActive immunotherapy with low-dose naltrexone (LDN) that activates the immune system
Molecular Target Opioid receptor (OPR)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today